Both in Biotechnology
Halozyme Therapeutics vs Neurocrine Biosciences
Over the past year HALO returned +91.5% and NBIX returned +16.0%; their daily moves had a correlation of 0.28.
HALO +91.5% NBIX +16.0%Growth of $1, one year, split-adjusted
| Metric | HALO | NBIX |
|---|---|---|
| Price | $130.34 | $166.05 |
| Market cap | $14.79B | $16.88B |
| Today | +1.34% | +0.73% |
| 1 month | +18.8% | +14.1% |
| 6 months | +96.4% | +12.9% |
| Year to date | +93.7% | +17.1% |
| 1 year | +96.9% | +17.0% |
| Revenue growth (YoY) | +47.7% | +41.2% |
| Gross margin | 83.5% | 97.6% |
| Net margin | 47.8% | 18.4% |
| P/E (TTM) | 35.8× | 24.0× |
| Price / sales | 8.9× | 4.6× |
| Net cash | -$1.92B | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 27.9% | 36.5% |
| Short % of float | 12.4% | 6.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).